CARLSBAD, Calif., Aug. 30,
2022 /PRNewswire/ -- Ionis Pharmaceuticals, Inc.
(Nasdaq: IONS) today announced that management will participate in
fireside chats at the following investor conferences:
- 2022 Wells Fargo Healthcare Conference on Wednesday, September 7, 2022
- Citi's 17th Annual BioPharma Conference on
Thursday, September 8, 2022
- Morgan Stanley 20th Annual Global Healthcare
Conference on Monday, September 12,
2022
A live webcast and additional information about each fireside
chat can be accessed on the Investors & Media section of the
Ionis website at www.ionispharma.com. Replays will be available on
the Ionis website within 48 hours of each event.
About Ionis Pharmaceuticals, Inc.
For more than 30
years, Ionis has been the leader in RNA-targeted therapy,
pioneering new markets and changing standards of care with its
novel antisense technology. Ionis currently has three marketed
medicines and a premier late-stage pipeline highlighted by industry
leading cardiovascular and neurological franchises. Our scientific
innovation began and continues with the knowledge that sick people
depend on us, which fuels our vision of becoming a leading, fully
integrated biotechnology company.
To learn more about Ionis, visit www.ionispharma.com and follow
us on Twitter @ionispharma
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-upcoming-investor-conferences-301614126.html
SOURCE Ionis Pharmaceuticals, Inc.